
SAVE THE DATES for the Joint EBJIS-MSIS 2026 Conference!
Dear colleagues and friends,
It is our great pleasure to announce the Joint EBJIS–MSIS 2026 Conference, taking place in Porto, Portugal, on 17–19 September 2026.
Next year’s Annual Meeting will be held in collaboration with the Musculoskeletal Infection Society (MSIS). We believe this partnership will foster valuable exchange of knowledge and strengthen collaboration across the ocean.
The conference will bring together experts, practitioners and companies involved in the treatment of bone and joint infections. Professionals attending the conference will benefit from high-level scientific presentations, knowledge sharing and networking opportunities.
Mark your calendars and don’t miss out on this opportunity to advance your knowledge and network with the best in the field.
We look forward to welcoming you in Porto in 2026!
On behalf of the EBJIS Executive Committee, the MSIS Board, and the 2026 Local Organising Committee,

Ricardo Sousa
EBJIS Past President

André Grenho
EBJIS 2026 Local Chair

Kenneth Urish
MSIS President
The 2026 Key Session Topics
- Europe vs North America I: DAIR – A clash of protocols
- Europe vs North America Showdown II: Staged Revision – How Much Is Enough? One, 1.5 or More?
- Europe vs North America Showdown III: Antibiotic Strategies – Same Bugs, Different Logic?
- Europe vs North America Showdown IV: Plastic Surgery’s Role – Does It Influence Staging Strategy in Fracture-Related Infection?
- Europe vs North America Showdown V: Prevention & Preop Assessment – Diverging Approaches?
- BJI Outcome Metrics: Measuring What Matters
- MDR Gram‑Negatives: The New Frontier of Resistance
- From Definition to Classification: Evolving the PJI Framework
- Spinal Infection in Focus: Bridging Definitions and Strategies
- Not Just another Joint: What Makes Shoulder Infections Different?
Important dates
- Abstract submission opens: December 2025
- Registration opens: January 2026
- Abstract submission deadline: 15 April 2026
- Early registration deadline: 1 July 2026